InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the “Protein Expression Market”-, By Type of Protein Expression System (Algal, Cell-free, Insect, Mammalian, Prokaryotic and Yeast), Protein Expression-related Offerings (Competent Cells, Expression Vectors, Instruments, Kits and Reagents, and Protein Expression Services), Application Area (Research and Diagnostics, and Therapeutics), End-users (Academic and Research Institutes, CROs and CDMOs, Pharmaceutical / Biotechnology Companies, and Other End-users), Type of Operation (In-house and Outsourced Operations), Industry Trends, and Global Forecasts, 2024-2031 And Segment Revenue and Forecast To 2031.”
The Protein Expression Market is estimated to reach over USD 4.6 billion by 2031, exhibiting a CAGR of 7.7% during the forecast period.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2823
Protein expression encompasses the synthesis, regulation, and post-translational modification of proteins within living systems, utilizing competent cells, expression vectors, reagents, and specialized tools and services. Reagents, due to their extensive application in protein expression workflows, are projected to capture the largest market share.
The global protein expression market is poised for substantial growth, driven by increased funding from governmental and private organizations, rising prevalence of chronic diseases, and the ongoing expansion of the life sciences sector. Additionally, the growing demand for protein-based therapeutics and the increasing incidence of chronic conditions are expected to further accelerate market development over the forecast period.
The proliferation of contract research organizations (CROs) and contract development and manufacturing organizations (CDMOs) has created opportunities for outsourcing protein production, enabling companies to focus on core research and development activities. Concurrently, advancements in expression systems, including plant- and yeast-based platforms, are offering more efficient and sustainable methods for producing complex proteins.
The rising pipeline of biologics and biosimilars is intensifying the demand for sophisticated protein expression technologies, which are critical for the production of therapeutic proteins, including monoclonal antibodies and vaccines. Sustained investments from both public and private sectors in protein research, biotechnology innovation, and drug development continue to drive the adoption of protein expression solutions, supporting both academic research initiatives and commercial-scale manufacturing.
List of Prominent Players in the Protein Expression Market:
- Agilent Technologies
- Ajinomoto Bio-Pharma Services
- Aldevron
- ARTES Biotechnology GmbH
- Bio-Rad Laboratories
- BIONEER CORPORATION
- Cayman Chemical
- Charles River Laboratories
- CORNING INCORPORATED
- Domainex
- DANAHER CORPORATION
- Eurofins CALIXAR
- FUJIFILM IRVINE SCIENTIFIC, INC.
- GeNext Genomics
- GenScript Biotech
- Lonza
- Lucigen Corporation
- LifeSensors Inc
- LEADING BIOLOGY, INC.
- Merck KGaA
- New England Biolabs
- Oxford Expression Technologies
- ProMab
- Promega
- ProteoGenix
- Peak Proteins Ltd
- QIAGEN
- Sartorius
- Synbio Technologies
- Syngene
- Synthetic Genomics Inc
- Sino Biological Inc
- JENA BIOSCIENCE
- Takara Bio
- Thermo Fisher Scientific
- WuXi Biologics
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-01
Market Dynamics
Drivers:
The protein expression market is primarily driven by the increasing adoption of biologics, including therapeutic proteins, monoclonal antibodies, and vaccines, for the treatment of oncology, autoimmune disorders, and other chronic diseases. Given the structural complexity of biologics compared to conventional small-molecule drugs, advanced and efficient protein expression platforms are essential for their development.
The rapid growth of the biotechnology and pharmaceutical sectors is further propelling demand for these technologies, which support novel drug discovery, personalized medicine, and the large-scale production of therapeutic proteins. Innovations across various expression systems—including mammalian, yeast, plant-based, insect, and cell-free platforms—are enhancing process efficiency, scalability, and sustainability, thereby accelerating market expansion.
Challenges:
The production of structurally complex proteins, particularly those requiring post-translational modifications such as glycosylation, remains a critical challenge. Prokaryotic expression systems, such as Escherichia coli, often face limitations in generating correctly folded or modified proteins, necessitating the use of more sophisticated and costly platforms, such as mammalian cell systems, which can accurately produce complex proteins with proper modifications.
Regional Trends:
North America, led by the United States, continues to hold the largest share of the protein expression market, supported by a mature biotechnology and pharmaceutical ecosystem, robust R&D investments, and high healthcare expenditures. The rising prevalence of chronic diseases, including cancer and autoimmune disorders, has further fueled demand for therapeutic proteins such as monoclonal antibodies and vaccines.
Meanwhile, the Asia-Pacific region is expected to register the fastest market growth, driven by increased biotechnology investments, expanding pharmaceutical manufacturing capabilities, and rising healthcare needs. The region has emerged as a global hub for outsourcing protein expression and biopharmaceutical production, offering cost advantages, skilled labor, and favorable infrastructure, which has attracted significant participation from multinational companies.
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2823
Recent Developments:
- In June 2024, HERCULES, Calif.,Bio-Rad Laboratories, Inc. The launch of the ddSEQTM Single-Cell 3′ RNA-Seq Kit and corresponding Omnition v1.1 analysis software for single-cell transcriptome and gene expression research was announced by a global leader in life science research and clinical diagnostics products.
- In April 2023, Eurofins CALIXAR, declared the purchase of CALIXAR, a pioneer in providing the best membrane proteins for the life sciences. The purchase strengthens Eurofins Discovery and Eurofins DiscoverX®’s scientific leadership in G Protein-Coupled Receptors (GPCRs) and ion channels and provides critical capabilities in membrane protein synthesis of highly druggable targets. Gaining more knowledge in these crucial fields enhances the business’s Biophysics and Biotherapeutics platforms, as well as its Integrated Drug Discovery platform, DiscoveryOneTM.
- In March 20022, ProteoGenix, declares the release of its transient expression system, XtenCHOTM. In comparison to previous methods, the novel patented mammalian cell-based expression host produces up to ten times higher yields with less hands-on time because of its optimised metabolism and enhanced plasmid stability. The novel CHO host seeks to expedite early phase drug screening and streamline the manufacture of recombinant proteins.
Segmentation of Protein Expression Market.
Global Protein Expression Market– By Type of Protein Expression System
- Algal Expression Systems
- Cell-free Expression Systems
- Insect Expression Systems
- Mammalian Expression Systems
- Prokaryotic Expression Systems
- Yeast Expression Systems
Global Protein Expression Market – Protein Expression-related Offerings
- Competent Cells
- Expression Vectors
- Instruments
- Kits and Reagents
- Protein Expression Services
Global Protein Expression Market – By Application
- Research and Diagnostics
- Therapeutics
Global Protein Expression Market – By End user
- Academic and Research Institutes
- CROs and CDMOs
- Pharmaceutical and Biotechnology Companies
- Other End-users
- Type of Operation
- In-house Operations
- Outsourced Operations
Global Protein Expression Market – Type of Operation
- In-house Operations
- Outsourced Operations
Global Protein Expression Market – By Region
North America-
- The US
- Canada
- Mexico
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of the Middle East and Africa
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: https://www.insightaceanalytic.com/
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com
